|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Pulmatrix Snags $14M, Embera Adds for $4.5 Addiction Drugs, Daktari Gets $1.2M, & More Boston-Area Life Sciences News
|
Erin Kutz |
08/19/11 |
Boston
|
|
Bristol-Myers Acquires Amira Pharmaceuticals for $325 Million, Scoops Up Lung Drug
|
Luke Timmerman |
07/21/11 |
San Diego
|
|
InterMune Wins EU Approval
|
Luke Timmerman |
03/03/11 |
San Francisco
|
|
Pearl Hires New CEO
|
Luke Timmerman |
02/24/11 |
San Francisco
|
|
Stromedix Chief, After Reloading the Company Treasury, Sets Sight on Trial for Deadly Lung Disease
|
Ryan McBride |
02/07/11 |
Boston
|
|
PneumRx Raises $33M
|
Wade Roush |
01/04/11 |
San Francisco
|
|
Intermune Gets EU Advisory Nod; Shares Boom
|
Luke Timmerman |
12/17/10 |
San Francisco
|
|
Montgomery Joins Alder Board
|
Luke Timmerman |
11/01/10 |
Seattle
|
|
Spiration Borrows $6.5M
|
Luke Timmerman |
04/28/10 |
Seattle
|
|
Uptake Medical Nabs $3.4M
|
Luke Timmerman |
09/11/09 |
Seattle
|
|
Visible Raises $6M, Vulcan Goes Deep with BiPar, IdeaScale Serves White House, & More Seattle-Area Deals News
|
Gregory T. Huang |
05/26/09 |
Seattle
|
|
CMC Icos to Make Lung Drug
|
Luke Timmerman |
05/11/09 |
Seattle
|
|
$2.6M Helps Healionics Heal, Uptake Takes In $3M, BlueKai Gets $10.5M Boost, & More Seattle-Area Deals News
|
Gregory T. Huang |
12/16/08 |
Seattle
|
|
Aires Pharmaceuticals Emerges from Stealth Mode With Drug for Pulmonary Arterial Hypertension
|
Luke Timmerman |
11/05/08 |
San Diego
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
